Last reviewed · How we verify
Muscle Spasticity due to Multiple Sclerosis
Approved treatments
- Sativex · Jazz Pharmaceuticals
- Cannabinoids · New York State Psychiatric Institute
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Muscle Spasticity due to Multiple Sclerosis patent landscape — cliff calendar, originator estates, attackable patents
- Muscle Spasticity due to Multiple Sclerosis treatment landscape brief
- Muscle Spasticity due to Multiple Sclerosis treatment updates RSS
Frequently asked questions about Muscle Spasticity due to Multiple Sclerosis
What drugs treat Muscle Spasticity due to Multiple Sclerosis?
Tracked treatments include Sativex, Cannabinoids.
What is the treatment for Muscle Spasticity due to Multiple Sclerosis?
Standard treatment for Muscle Spasticity due to Multiple Sclerosis includes Sativex, Cannabinoids. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Muscle Spasticity due to Multiple Sclerosis patent cliff · Muscle Spasticity due to Multiple Sclerosis CI report
- Treatment: Sativex · Jazz Pharmaceuticals
- Treatment: Cannabinoids · New York State Psychiatric Institute
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing